Prostaglandin E2 glyceryl ester is an endogenous agonist of the nucleotide receptor P2Y6-Reference-Cited by-同舟云学术

Prostaglandin E2 glyceryl ester is an endogenous agonist of the nucleotide receptor P2Y6

Published:2017-05-24 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Brüser Antje,Zimmermann Anne,Crews Brenda C.,Sliwoski Gregory,Meiler Jens,König Gabriele M.,Kostenis Evi,Lede Vera,Marnett Lawrence J.,Schöneberg Torsten

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-02414-8.pdf

Reference74 articles.

1. Smith, W. L. Prostanoid biosynthesis and mechanisms of action. The American journal of physiology 263, F181–91 (1992).

2. Kozak, K. R., Rowlinson, S. W. & Marnett, L. J. Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2. The Journal of biological chemistry 275, 33744–33749 (2000).

3. Kozak, K. R. et al. Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides. The Journal of biological chemistry 277, 44877–44885 (2002).

4. Kozak, K. R. et al. Metabolism of prostaglandin glycerol esters and prostaglandin ethanolamides in vitro and in vivo. The Journal of biological chemistry 276, 36993–36998 (2001).

5. Alhouayek, M., Masquelier, J., Cani, P. D., Lambert, D. M. & Muccioli, G. G. Implication of the anti-inflammatory bioactive lipid prostaglandin D2-glycerol ester in the control of macrophage activation and inflammation by ABHD6. Proceedings of the National Academy of Sciences of the United States of America 110, 17558–17563 (2013).

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Temporal dissociation of COX-2-dependent arachidonic acid and 2-arachidonoylglycerol metabolism in RAW264.7 macrophages;Journal of Lipid Research;2024-09

2. Chiral Me-2-arachidonoyl Glycerols: The First Potent Endocannabinoid Glyceride Templates with Stability to COX-2;ACS Medicinal Chemistry Letters;2024-05-28

3. Inflammation and cancer: friend or foe?;Frontiers in Pharmacology;2024-05-10

4. Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years;Pharmacological Reviews;2023-05-10

5. African American Women with Cardiometabolic Complications of Pregnancy Have Decreased Serum Abundance of Specialized Pro-Resolving Lipid Mediators and Endocannabinoids;Nutrients;2022-12-28